Navigation Links
The 'febit science lounge' presents: Webinar About Role of Non-Protein-Coding RNA in Human Genome Set for 11 a.m. EDT on June 12
Date:6/5/2008

'The human genome as an RNA machine' with Prof. John Mattick with Institute

for Molecular Bioscience at University of Queensland, Australia

LEXINGTON, Mass. and HEIDELBERG, Germany, June 5 /PRNewswire/ -- febit holding gmbh today unveiled plans for the first of a series of educational Webinars geared for genomics researchers worldwide.

Moderated by febit's chief scientific officer, Peer Staehler, the first Webinar, which is set for 11 a.m. EDT on June 12, will feature John Mattick, Ph.D., a world-renowned researcher whose focus is the role of non-protein-coding ("junk") RNA in relation to the evolution and development of complex organisms.

"Genetic information that programs complex organisms lie in non-protein coding RNA," said Dr. Mattick, foundation professor of molecular biology and director of the Centre for Molecular Biology and Biotechnology, with the Institute for Molecular Bioscience at the University of Queensland, Australia. "This massive hidden network of regulatory information directs the precise patterns of gene expression during growth and development."

Mr. Staehler added: "This educational Webinar for the genomics researchers is the first of many to come. The team at febit is dedicated to support researchers to solve the challenge of understanding biological processes."

To participate in the Webinar, register at http://www.febit.com. Please connect to the Webinar several minutes prior to the start time to ensure adequate time for any software download that may be necessary. The live event may also be accessed by dialing 877-715-5318 (for U.S. callers) and 973-582-2852 (for international callers) and entering conference ID 50057678. Questions may be asked over the telephone during the live event or e-mailed in advance to webinar@febit.com. The Webinar will be available for replay for one year on febit's Web site.

About febit

febit enables scientists to read, write and understand the code of life: DNA. With its unique Geniom technology and services, febit is the only company that puts the control of simplified genomic research in the hand of the user. The seamless integration of DNA synthesis and analysis and the superior support in experiment design and bioinformatics helps to understand data and turn it into results. febit's team of experienced scientists is dedicated to support customers to solve the challenge of understanding biological processes. Geniom is a technological and service platform successfully implemented in basic and applied research by renowned institutions and companies. Geniom exploits cutting-edge microarray technology for analysis and synthesis of genes and genomes, providing superior time- and cost-efficiency combined with an unsurpassed spectrum of applications.

http://www.febit.com

Contact:

febit holding gmbh Russo Partners, LLC

Eva Sterzel David Schull or Wendy Lau

Public Relations Manager +1-212-845-4271

+49 (6221) 6510-300 david.schull@russopartnersllc.com

eva.sterzel@febit.de wendy.lau@russopartnersllc.com


'/>"/>
SOURCE febit
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay
2. Penn scientist receives LOréal USA fellowship for women in science
3. Edwards Lifesciences to Present at the Goldman Sachs 29th Annual Global Healthcare Conference
4. Derma Sciences Announces Numerous Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming WUWHS Conference
5. Medical Simulation Corporation Announces Partnership With Seattle Science Foundation
6. Edwards Lifesciences Receives Additional Questions From the FDA About the LifeStent Product Line
7. New federally-funded health initiative to speed benefits of science to North Carolinians
8. Harvard Medical School receives major NIH grant for galvanizing translational science
9. BUMC, BMC receives Clinical and Translational Science Award from NIH
10. Experts to discuss sleep science and the health risks of sleep disorders in Baltimore this June
11. 1 small step for a lab science, 1 green leap for mankind
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... , ... The American public tends to feel uncomfortable about drinking recycled waste ... or well water. The recent experience with lead contaminated water in Flint, Michigan, according ... toward increasing public acceptance of recycled waste water as drinking water. , The ...
(Date:2/5/2016)... SARASOTA, Fla., (PRWEB) , ... February 05, 2016 , ... ... appetizing recipes just in time for this weekend’s Big Game. Take the stress out ... ingredients that will keep your guests happy at every stage of the game. , ...
(Date:2/5/2016)... ... February 05, 2016 , ... Dr. Justin Scott and ... 2nd Annual No Cost Dental Day to individuals in need. The event is scheduled ... this No Cost Dental Day is to provide dental care to community members in ...
(Date:2/5/2016)... ... February 05, 2016 , ... Colorize is a web ... zone to the next using Colorize's dynamic moving camera. Colorize is perfect for personal ... a 3D slideshow environment with 1 to 5 focus points per scene, stage floor ...
(Date:2/5/2016)... ... , ... California Mobile Kitchens , a company that ... mobile kitchen model, featuring customizable stainless steel interiors and a new, 26-foot unit. ... anywhere in the U.S. Many of their units can be seen at sporting ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... Global Immunology Market to 2022 - ... market growth Summary Immune-mediated inflammatory diseases ... that affect 5–7% of western populations. Although they ... and key patient demographics, they are pathophysiologically linked, ... an inappropriate immune response. Generally, disease-modifying anti-rheumatic drugs, ...
(Date:2/4/2016)... Feb. 4, 2016 Mettler-Toledo International Inc. (NYSE: ... 2015.  Provided below are the highlights: , ... compared with the prior year.  Reported sales decreased 3% ... quarter. , Net earnings per diluted share as ... prior- year period.  Adjusted EPS was $4.65, an increase ...
(Date:2/4/2016)... 4, 2016  AMRI (NASDAQ:  AMRI) today announced that ... and President of Pfizer Global Supply, has been elected to ... 2016. In addition, the Company announced that Mr. Gabe ... since 2010, has retired from the AMRI Board of Directors ... other business ventures.  William S. Marth , ...
Breaking Medicine Technology: